Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine

Acta Neurologica Scandinavica

Volumn 127, Issue S196, 2013, Pages 11-15

  Svalheim, S ^a   Mushtaq, U ^a   Mochol, M ^b   Luef, G ^c   Rauchenzauner, M ^d   Froland S S ^e,f   Tauboll E ^a,f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Østfold County Hospital   (Norway)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d St Vincent's Hospital Zams   (Austria)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Carbamazepine; Epilepsy; Hypogammaglobulinemia; Lamotrigine; Levetiracetam

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; LAMOTRIGINE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PIRACETAM; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DRINKING BEHAVIOR; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICAL ACTIVITY; SMOKING; ADOLESCENT; BLOOD; CLASSIFICATION; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MIDDLE AGED; NONPARAMETRIC TEST; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; BODY MASS INDEX; CARBAMAZEPINE; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PIRACETAM; STATISTICS, NONPARAMETRIC; TRIAZINES; YOUNG ADULT;

EID: 84870403266     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12044     Document Type: Article

References (19)

1. Sorrell TC, Forbes IJ, Burkness FR, Rischbieth RHC. Depression of immunological function in patients treated with phenytoin sodium (diphenylhydantoin). Lancet 1971;4:1233-5.
2. Sorrell TC, Forbes IJ. Depression of immune competence by phenytoin and carbamazepine. Clin Exp Immunol 1975;20:273-85.
3. Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum 2009;39:18-29.
4. Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. J Neurol 1981;226:56-61.
5. Pereira LF, Sanchez JF. Reversible panhypogammaglobulinemia associated with phenytoin treatment. Scand J Infect Dis 2002;34:785-7.
6. Basaran N, Hincal F, Kansu E, Ciger A. Humoral and cellular immune parameters in untreated and phenytoin or carbamazepine treated epileptic patients. Int J Immunopharmacol 1994;16:1071-7.
7. Ashrafi MR, Hosseini SA, Biglari M et al. Effect of anti-epileptic drugs on serum level of IgG subclasses. Iran J Pediatr 2010;20:269-76.
8. Gilhus NE, Strandjord R, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations. Acta Neurol Scand 1982;66:172-9.
9. Gilhus NE, Matre R. Carbamazepine effects on mononuclear blood cells in epileptic patients. Acta Neurol Scand 1986;74:181-5.
10. Castro APB, Redmershi MG, Pastorino AC, da Paz JA, Ferraz Fomin AB, Abe Jacob CM. Secondary hypogammaglobulinemia after use of carbamazepine: case report and review. Rev Hosp Clin Fac Med Sao Paulo 2001;56:189-92.
11. Azar AE, Ballas ZK. Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam. Ann Allergy Asthma Immunol 2008;101:108-9.
12. Gallerani M, Mari E, Boari B, Carletti R, Marra A, Cavallo M. Pancytopenia associated with levetiracetam treatment. Clin Drug Invest 2009;29:747-51.
13. Smith J, Fernando T, McGrath N, Ameratunga R. Lamotrigine-induced common variable immune deficiency. Neurology 2004;62:833-4.
14. Rosen FS, Eibl MM, Roifman CM et al. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological societies. Clin Exp Immunol 1999;118(Suppl. 1):1-28.
15. Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 2004;3:211-7.
16. Callenbach PM, Jol-Van Der Zijde CM, Geerts AT et al. Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol 2003;132:144-51.
17. Eeg-Olofsson O, Osterland CK, Guttmann RD et al. Immunological studies in focal epilepsy. Acta Neurol Scand 1988;78:358-68.
18. Fontana A, Grob PJ, Sauter R, Joller H. IgA deficiency, epilepsy, and hydantoin medication. Lancet 1976;2:228-31.
19. Van Engelen BG, Weemaes CM, Renier WO, Bakkeren JA, Borm GF, Strengers PF. A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand J Immunol 1995;41:209-13.